Poka-Yoke Pharmaceuticals
King Pharmaceutical (NYSE: KG) recently had a drug approved by the Food and Drug Administration (FDA). Their drug, Embeda, has an interesting property: If you take the medication as prescribed, it works fine; if you abuse the medication, it ceases to work. This is Poka-Yoke (ポカヨケ) for Pharmaceutical drugs.
Poka-Yoke (ポカヨケ), translated, means mistake-proof, or fail-proof. In it’s simplest form, it is a method that prevents failures. Poka-Yoke is a critical piece in Lean Thinking, pioneered by Shigeo Shingo. Examples of Poka-Yoke might include:
- Clocky, a clock that prevents you from sleeping-in
- A Key can enter a keyhole in only one way
- Needle cap, to prevent needle pin pricks
- A Microwave stops working, when the door is opened
- Aza Raskin explains Poka-Yoke for Humane Interfaces (Aza is a friend of shmula & his dad invented the Macintosh – Jef Raskin)
In their FDA approval press release:
We are focused on developing medicines that use novel technologies designed to reduce drug liking and make it more difficult to extract the active ingredient. We anticipate a September 2009 launch for EMBEDA (TM).
Utilizing King’s proprietary technology, EMBEDA(TM) contains extended-release morphine pellets, each with an inner core of naltrexone hydrochloride, an opioid receptor antagonist. If taken as directed, the morphine relieves pain while the sequestered naltrexone hydrochloride passes through the body with no intended clinical effect. If EMBEDA(TM) is crushed or chewed, the naltrexone is released and absorbed with the morphine, reversing the morphine’s subjective and analgesic effects.
At the heart of Poka-Yoke is Prevention and an awareness of Human Frailty: we want to stop problems before they occur. Indeed, preventing abuse, addiction, medication dependence, tragedy to the individual and families, or death, is a novel and innovative use for Poka-Yoke.
WP Cumulus Flash tag cloud by Roy Tanck and Luke Morton requires Flash Player 9 or better.
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
@backtype: nice work, but lately it’s not picking-up on wp 2.8.4; post should have a few tweets http://is.gd/2oDXo, but none were picked-up
This comment was originally posted on Twitter
Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez
This comment was originally posted on Twitter
RT @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez
This comment was originally posted on Twitter
Great example – should become the standard RT @leanblog Brilliant error proofing a pharmaceutical against abuse http://bit.ly/W33ez
This comment was originally posted on Twitter
RT @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez
This comment was originally posted on Twitter
RT @GrahamHill @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez
This comment was originally posted on Twitter
RT @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez [via @GrahamHill ]
This comment was originally posted on Twitter
RT @ethicsblogger RT @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez [via @GrahamHill ]
This comment was originally posted on Twitter
Poka Yoke rts @ethicsblogger @leanblog: Brilliant – error proofing a pharmaceutical against abuse http://bit.ly/W33ez [via @GrahamHill ]
This comment was originally posted on Twitter
Poka-Yoke Pharmaceuticals http://bit.ly/7k4vA (via feedly) #lean
This comment was originally posted on Twitter
Poka-Yoke Pharmaceuticals http://bit.ly/7k4vA (via feedly) #lean
This comment was originally posted on Twitter
Regarding addiction as a brain disorder, medical in nature, this is treatment within treatment. I wonder if the naltrexone would also inhibit the patient from using any other opiates while being treated for pain.
[...] Peter Abilla offers a great new example of design that accommodates human frailty: Embeda, a newly FDA-approved pain-killer with …an interesting property: If you take the medication as prescribed, it works fine; if you abuse the medication, it ceases to work. …EMBEDA(TM) contains extended-release morphine pellets, each with an inner core of naltrexone hydrochloride, an opioid receptor antagonist. If taken as directed, the morphine relieves pain while the sequestered naltrexone hydrochloride passes through the body with no intended clinical effect. If EMBEDA(TM) is crushed or chewed, the naltrexone is released and absorbed with the morphine, reversing the morphine’s subjective and analgesic effects. [...]
Leave a comment
Additional comments powered by BackType
blog post: Poka-Yoke Pharmaceuticals http://tinyurl.com/pfnp65
This comment was originally posted on Twitter